ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...
SHENZHEN, GUANGDONG, CHINA, January 7, 2026 /EINPresswire.com/ -- The Electrifying Future: Global Demands and the Quest ...
Thermal processing technology has come a long way, but food & beverage processors still seek more consistency, stability and ...
AB-1009 is an investigational gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been established or fully evaluated. For more information, ...
TEGUAR and SORBA.ai Announce Strategic Hardware Partnership to Accelerate On-Prem Industrial AI Deployment in Critical Environments JACKSONVILLE, FL, UNITED STATES, January 5, 2026 /EINPresswire.com/ ...
Researchers at the University of St Andrews have uncovered a long‑elusive molecular "reshuffle," a breakthrough that tackles ...
The company’s engineering heritage, combined with continuous investment in process automation and digital manufacturing, ...
Don Cowan and Mahyar Mohammadnezhad of Kiwa PI Berlin explain the importance of upstream diligence in ensuring long-term PV ...
Hill Helicopters engineered composite main rotor blades using a novel single-cure manufacturing process for stiffness and ...
Edge platforms, which provide a liaison between networks and legacy equipment, can provide a layer of cybersecurity ...
FZE Manufacturing Solutions today announced increased visibility into its vertical machining center capabilities as part of its broader CNC machining services, reflecting continued investment in ...
Intel recently confirmed the latest results in its partnership with ASML. The US chipmaker worked with engineers from the European corporation to install, test, and validate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback